H.E.R.O.S. Study: An Observational Study of the Cardiac Safety of Herceptin (Trastuzumab) in Patients With HER2-Positive Breast Cancer

NCT01991340 · clinicaltrials.gov ↗
COMPLETED
Status
657
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Hoffmann-La Roche